AVE 33.3% 0.2¢ avecho biotechnology limited

novartis and poh ease the pain, page-7

  1. 1,053 Posts.
    lightbulb Created with Sketch. 4
    Yes Themis ready to go - just waiting for Novartis to launch first/concurrent - was part of the agreement I am reliably informed so I would assume Novartis are planning some kind of marketing blitz to differentiate themselves from the generic.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.